CEPSA has begun constructing a plant to produce 80,000 mt of isopropyl alcohol in Spain. The new facility represents an investment of € 75 million. The facility will be able to replace fossil-based raw materials with sustainable materials, thereby reinforcing CEPSA's Positive Motion strategy to drive the energy transition.
German biotech company BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) are expanding their strategic partnership to contribute to building a sustainable and resilient end-to-end African vaccine ecosystem. The partners said that CEPI will commit up to $145 million to support BioNTech to establish mRNA vaccine R&D as well as clinical and commercial-scale manufacturing capabilities at the company’s facility in Kigali, Rwanda.
Aurigene Pharmaceutical Services Limited (Aurigene), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 6500 m2 (70,000 sq ft) in Hyderabad, India.
UK-headquartered contract development and manufacturing organization (CDMO) Sterling Pharma Solutions has invested $3 million at its US facility in Germantown, WI, to expand the company’s integrated antibody-drug conjugate (ADC) development and manufacturing capabilities.
Enzene Biosciences, a global CDMO announces the launch of a new Drug Discovery Division.
South Korean conglomerate Hanwha and Ineos Nitriles intend to collaborate in a study for a low-carbon ammonia facility with carbon sequestration in the US, with a capacity of more than 1 million tons per annum.
Eli Lilly plans to invest another $5.3 billion in its US manufacturing site Lebanon, Indiana, increasing the company's total investment in this site $9 billion. The investment will expand Lilly's capacity to manufacture active pharmaceutical ingredients (API) for tirzepatide injections marketed under the Zepbound and Mounjaro brands.
In a move to enhance global supply of its antibody drug conjugates (ADCs) portfolio, AstraZeneca intends to build a $1.5 billion facility in Singapore for the manufacturing of ADCs.
Hungarian energy and petrochemicals group MOL has inaugurated its €1.3 billion polyol complex in Tiszaújváros, Hungary, with a capacity of around 200,000 t/y of polyol, a widely used plastic raw material.
BASF is to invest in the expansion of its advanced additives plant at Nanjing, China. The expansion includes a state-of-the-art production line for the company’s high-performance controlled free radical polymerization (CFRP) dispersants used in the coatings industry. The new line is planned to start up by the end of 2025.
US-headquartered specialty chemicals company Orion announced plans to invest in Alpha Carbone, a French tire recycling company. The partnership will enable Alpha Carbone to scale up its facility in Dole, France, and produce commercial volumes of tire pyrolysis oil and recovered carbon black.
On Monday, Paris-based French drugmaker Sanofi announced plans to invest more than €1 billion at three facilities in France to create new bioproduction capacity.
China State Shipbuilding Corporation (CSSC) will construct 18 giant liquefied natural gas (LNG) vessels for QatarEnergy under a deal worth $6 billion.
On Wednesday, China’s Wanhua Chemical opened its R&D center in Cornellà de Llobregat near Barcelona, Spain, providing technical support and services to downstream customers in fine chemicals and materials on topics like product performance, application methods, and raw material selection.
On Thursday, Syensqo broke ground on its new battery-grade polyvinylidene fluoride (PVDF) facility in Augusta, Georgia, US. When complete, the site will be the largest PVDF production facility in North America, the company said.
Asahi Kasei announced that it will construct an integrated plant in Ontario, Canada for the base film manufacturing and coating of Hipore wet-process lithium-ion battery (LIB) separator. Asahi Kasei and Honda Motor Co., Ltd. (Honda) have reached a basic agreement about the plant and are currently exploring the possibility of a joint investment.
Last week, LyondellBasell and Genox Recycling have opened their plastics recycling joint venture (JV) in Zhaoqing, Guangdong Province, China, which will operate under the name Guangdong Genox LyondellBasell New Material Co.
Linde announced that – through its subsidiary White Martins – will build, own and operate a second 5-MW pressurized alkaline electrolyzer to produce green hydrogen in Jacareí, São Paulo, Brazil. Start-up of the facility is expected in 2025.
Belgian chemical major Solvay has opened a new facility in Rosignano, Italy, for the production of Alve-One, a chemical blowing agent for the thermoplastic foaming industry.
BASF has started operations at its prototype metal refinery for battery recycling in Schwarzheide, Germany. The plant enables the development of operational procedures and the optimization of innovative battery recycling technology, processing end-of-life lithium-ion batteries and battery production scrap, the company said.
US-based Vantage Specialty Chemicals is to expand taurate capacity at its major manufacturing site in Leuna, Germany, in particular for the production of N-methyltaurine.
As part of its strategy to expand the company's application portfolio, Germany-based OQ Chemicals has mechanically completed the expansion of its US plant in Bay City, Texas, for the production of high-purity propionaldehyde.
Fujifilm announced an additional investment of $1.2 billion in its large-scale cell culture contract development and manufacturing organization (CDMO) business to further expand the planned Fujifilm Diosynth Biotechnologies facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion. Plans for the new site were unveiled in September last year.
Air Liquide is to expand its capacities in biomethane, also known as renewable natural gas (RNG) in the US, with the construction of two new production units. These units, located in Center Township, Pennsylvania, and Holland Township, Michigan, will treat waste sourced from dairy farms.
Novoloop, a plastic circular economy technology company, recently announced the successful startup of its pilot plant in India in collaboration with Aether Industries, a publicly listed specialty chemicals manufacturer.
Specialty chemicals company Orion, a producer of carbon black, broke ground on a battery materials plant in Texas, US. According to Orion, the facility will be the only one in the US producing acetylene-based conductive additives for lithium-ion batteries and other applications for the growing electrification.
Roquette, a French multinational supplier of pharmaceutical and nutraceutical excipients, announced an investment by its venture capital arm Roquette Ventures in Danish start-up Biograil.
TotalEnergies and China Petroleum and Chemical Corporation (Sinopec) have agreed to develop a production unit for sustainable aviation fuel (SAF) at a Sinopec's refinery in China.
Upperton Pharma Solutions was joined by Sarah Gilbert, Professor and co-creator of the Oxford/AstraZeneca COVID-19 vaccine for the official opening of its new development and GMP manufacturing facility in Nottingham, UK.
Swiss specialty chemicals producer Archroma announced plans to expand its US operations in Martin, South Carolina.
Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen Biologics Pvt Ltd, has completed its first small-scale manufacturing project for a US-based organization, producing a novel anticancer monoclonal antibody.
Syensqo has opened its application development labs (ADL) in Bollate, Italy. The project includes an expansion of 1,300 m2 in a new building and represents a €10 million investment over the past three years and underlines the Bollate research center’s pivotal role in developing new applications for high-tech industries, the company said.
Sandoz, a generic and biosimilar medicines manufacturer, recently opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe.
Dow announced its intent to build a world-scale carbonate solvents production facility for lithium-ion battery production on the US Gulf Coast. The plant will serve customers in the lithium-ion battery sector, in which carbonate solvents are used as a component in electrolytes.
In a move to triple its production of glass and polymer syringes for the US market by 2030, Germany’s Schott Pharma announced plans to build its first US facility to manufacture prefillable polymer syringes that meet the need for deep-cold storage and transportation of mRNA medications.
